A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Major histocompatibility complex class II (MHC-II) molecules are crucial for immune responses by presenting peptides to T helper cells.
• MHC-II dysfunction is strongly implicated in the pathogenesis of autoimmune diseases.
• Understanding the regulation of MHC-II expression and transport is vital for developing therapeutic strategies.

Purpose of the Study:

• To identify novel regulators of tissue-specific MHC-II transcription.
• To elucidate the molecular mechanisms controlling MHC-II transport in dendritic cells.
• To integrate diverse datasets for a systems-level understanding of MHC-II antigen presentation.

Main Methods:

• Genome-wide RNAi screen using flow cytometry to assess MHC-II expression and peptide loading.
• High-throughput assays to validate initial findings.
• Bioinformatic integration of multiple large-scale datasets.

Main Results:

• Nine regulators were identified that control MHC-II transcription through feedback networks, with higher-order regulation by signaling pathways like TGFβ.
• The GTPase ARL14/ARF7, along with effector ARF7EP, was found to control MHC-II vesicle transport.
• This complex mediates MHC-II vesicle movement along the actin cytoskeleton in human dendritic cells (DCs).

Conclusions:

• This study provides a comprehensive systems-level analysis of MHC-II antigen presentation.
• Identified regulators and pathways offer potential targets for manipulating MHC-II presentation in infectious and autoimmune diseases.
• The findings advance our understanding of immune regulation and disease pathogenesis.